Jonathan G. Stine, MD MSc, FACP

@JonathanStineMD

Assistant Professor of Medicine and Public Health Sciences, Liver Center Research Director, Penn State Milton S. Hershey Medical Center

Hershey, PA
Vrijeme pridruživanja: srpanj 2019.

Tweetovi

Blokirali ste korisnika/cu @JonathanStineMD

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @JonathanStineMD

  1. Well done ! An inspiration to all junior hepatologists!

    Poništi
  2. Thanks for the RT

    Prikaži ovu nit
    Poništi
  3. 1️⃣While ACUTE reduces portal flow up to 80%, CHRONIC exercise does NOT CHANGE portal flow BUT 2️⃣HVPG significantly reduced in over 2 out of 5 subjects in SportDiet study and colleagues

    Prikaži ovu nit
    Poništi
  4. New article coming soon from our research group on risk of including possibility for to improve this

    Poništi
  5. Why is good for my ? Let's start with five reasons... more to follow 1️⃣Improves blood flow 2️⃣Lowers HVPG 3️⃣Improves 4️⃣Protects against damage 5️⃣Decrease in risk, including

    Poništi
  6. Guidance on from authored by et al. is out! Biggest take away-my argument for screening patients with for is endorsed if have either Clinical Decision Aid or Biomarker + Elasto showing F3

    Poništi
  7. This highlights the need for more accurate for diagnosis, and . ALT is a poor marker.

    Poništi
  8. Poništi
  9. proslijedio/la je Tweet
    31. sij

    Thinking of a special way to honor your mentor? Check out the Memorial Travel Award.

    Poništi
  10. Post hoc STOPAH analysis shows AUROC for transferrin is not great at 0.72 but similar to MELD, MDF and GAH scores for short and intermediate term mortality prediction

    Poništi
  11. Doing my best to walk the walk as an advocate for , , and by ascending leaderboard tonight...

    Poništi
  12. Consensus opinion from is to not use ASA for chemoprevention for either HCC or cholangio. Anyone have on why they don't do this despite multiple showing significant in each ?

    Poništi
  13. Looking for and for your and patients including those who require or have HCC? Check out website at

    Poništi
  14. Poništi
  15. Poništi
  16. Alright - do you use aspirin as chemo prevention for either HCC or cholangio?

    Poništi
  17. As a former awardee I can attest to the great benefit your donation will make in the career development of junior hepatologists and . Your gift funds

    Poništi
  18. Check out the program featuring our NASHFit Trial. Special is called Penn State Health- Clinical Trials: Research + You Full Broadcast via

    Poništi
  19. Looking forward to DOM annual state of the department lecture

    Poništi
  20. Will have to see how this shakes out for equity and access to

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·